Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lane

Showing results (781-790 of 923) with videos related to

Pageof 93
Sort By:
Oncogene|August 9, 2007
Detection of the p53 response in zebrafish embryos using new monoclonal antibodiesK-C Lee, W L P Goh, M Xu, et al.
Oncogene|May 1, 1993
Constitutional mutation in exon 8 of the p53 gene in a patient with multiple primary tumours: molecular and immunohistochemical findingsR A Eeles, W Warren, G Knee, et al.
Oncogene|June 6, 1996
Epitope analysis of the murine p53 tumour suppressor proteinD P Lane, C W Stephen, C A Midgley, et al.
Journal of Hospital Medicine|August 22, 2019
Improving Resident Feedback on Diagnostic Reasoning after Handovers: The LOOP ProjectKathleen P Lane, Catherine Chia, Juan N Lessing, et al.
British Journal of Cancer|December 1, 1994
Linkage studies in a Li-Fraumeni family with increased expression of p53 protein but no germline mutation in p53J M Birch, J Heighway, M D Teare, et al.
The Journal of Pathology|September 15, 2005
Discriminating functional and non-functional p53 in human tumours by p53 and MDM2 immunohistochemistryR Nenutil, J Smardova, S Pavlova, et al.
Chemistry & Biology|May 5, 2004
Structural determinants of CDK4 inhibition and design of selective ATP competitive inhibitorsCampbell McInnes, Shudong Wang, Sian Anderson, et al.
Cell Cycle (Georgetown, Tex.)|December 21, 2012
Wild-type and mutant p53 mediate cisplatin resistance through interaction and inhibition of active caspase-9Jacqueline L Y Chee, Suzan Saidin, David P Lane, et al.
Oncogene|June 27, 2012
The p53 isoform, Δ133p53α, stimulates angiogenesis and tumour progressionH Bernard, B Garmy-Susini, N Ainaoui, et al.
Molecular Cancer Therapeutics|January 20, 2005
Metabolism and pharmacokinetics of the cyclin-dependent kinase inhibitor R-roscovitine in the mouseBernard P Nutley, Florence I Raynaud, Stuart C Wilson, et al.
Pageof 93

Showing results (781-790 of 923) with videos related to

Sort By:
Pageof 93
Oncogene|August 9, 2007
Detection of the p53 response in zebrafish embryos using new monoclonal antibodiesK-C Lee, W L P Goh, M Xu, et al.
Oncogene|May 1, 1993
Constitutional mutation in exon 8 of the p53 gene in a patient with multiple primary tumours: molecular and immunohistochemical findingsR A Eeles, W Warren, G Knee, et al.
Oncogene|June 6, 1996
Epitope analysis of the murine p53 tumour suppressor proteinD P Lane, C W Stephen, C A Midgley, et al.
Journal of Hospital Medicine|August 22, 2019
Improving Resident Feedback on Diagnostic Reasoning after Handovers: The LOOP ProjectKathleen P Lane, Catherine Chia, Juan N Lessing, et al.
British Journal of Cancer|December 1, 1994
Linkage studies in a Li-Fraumeni family with increased expression of p53 protein but no germline mutation in p53J M Birch, J Heighway, M D Teare, et al.
The Journal of Pathology|September 15, 2005
Discriminating functional and non-functional p53 in human tumours by p53 and MDM2 immunohistochemistryR Nenutil, J Smardova, S Pavlova, et al.
Chemistry & Biology|May 5, 2004
Structural determinants of CDK4 inhibition and design of selective ATP competitive inhibitorsCampbell McInnes, Shudong Wang, Sian Anderson, et al.
Cell Cycle (Georgetown, Tex.)|December 21, 2012
Wild-type and mutant p53 mediate cisplatin resistance through interaction and inhibition of active caspase-9Jacqueline L Y Chee, Suzan Saidin, David P Lane, et al.
Oncogene|June 27, 2012
The p53 isoform, Δ133p53α, stimulates angiogenesis and tumour progressionH Bernard, B Garmy-Susini, N Ainaoui, et al.
Molecular Cancer Therapeutics|January 20, 2005
Metabolism and pharmacokinetics of the cyclin-dependent kinase inhibitor R-roscovitine in the mouseBernard P Nutley, Florence I Raynaud, Stuart C Wilson, et al.
Pageof 93